TCL Archive NCI Advisors Reject $30-Million Cohort Study, Approve Renewal of Phase I Clinical Trials Initiatives and American College of Radiology Imaging Network. July 7, 2006
TCL Archive Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker October 3, 2014